Breaking News
Get 40% Off 0
🎁 Free Gift Friday: Copy Legendary Investors' Portfolios in One Click Copy for Free
Close

OPC Pharmaceutical JSC (OPC)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
25,400.0 -100.0    -0.39%
08:45:08 - Closed. Currency in VND ( Disclaimer )
  • Volume: 2,600
  • Bid/Ask: 25,150.0 / 25,400.0
  • Day's Range: 25,350.0 - 25,500.0
Type:  Equity
Market:  Vietnam
ISIN:  VN000000OPC9 
OPC Pharmaceutical JSC 25,400.0 -100.0 -0.39%

OPC Income Statement & Profits

 
Assess the OPC Pharmaceutical JSC income statement, view the company's financial performance across their assets and liabilities. Select to view either quarterly or annual data.
AnnualQuarterly
Advanced Income Statement
Period Ending: 2024
31/03
2023
31/12
2023
30/09
2023
30/06
Total Revenue 221150.98 323451.91 222466.05 264108.32
Revenue 221150.98 323451.91 222466.05 264108.32
Other Revenue, Total - - - -
Cost of Revenue, Total 117001.73 193160.56 123949.2 153652.14
Gross Profit 104149.26 130291.35 98516.85 110456.19
Total Operating Expenses 178687.57 291304.94 183206.83 221450.3
Selling/General/Admin. Expenses, Total 61685.84 98144.38 59257.63 67798.16
Research & Development - - - -
Depreciation / Amortization 5589.06 -32.95 -35.77 -35.77
Interest Expense (Income) - Net Operating -80.97 - - -241.09
Unusual Expense (Income) - - - -
Other Operating Expenses, Total -5508.08 32.95 35.77 276.86
Operating Income 42463.42 32146.97 39259.22 42658.02
Interest Income (Expense), Net Non-Operating - - - -
Gain (Loss) on Sale of Assets - - - -
Other, Net 672.11 343.54 -641.07 -4372.59
Net Income Before Taxes 41791.31 31803.44 39900.29 47030.62
Provision for Income Taxes 8422.27 7591.81 8242.69 9520.87
Net Income After Taxes 33369.04 24211.62 31657.6 37509.75
Minority Interest 63630.85 62216.19 62533.86 62705.18
Equity In Affiliates - - - -
U.S GAAP Adjustment - - - -
Net Income Before Extraordinary Items 31954.38 24529.3 31828.91 36987.17
Total Extraordinary Items - - - -
Net Income 31954.38 24529.3 31828.91 36987.17
Total Adjustments to Net Income - - - -14089.6
Income Available to Common Excluding Extraordinary Items 31954.38 24529.3 31828.91 22897.57
Dilution Adjustment - - - 14101.3
Diluted Net Income 31954.38 24529.3 31828.91 22885.87
Diluted Weighted Average Shares 75.36 64.05 64.05 64.05
Diluted EPS Excluding Extraordinary Items 424 382.97 496.93 357.31
DPS - Common Stock Primary Issue - - - -
Diluted Normalized EPS 327.81 315.29 392.02 450.76
* In Millions of VND (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the income statement, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

OPC Price Commentary

Write your thoughts about OPC Pharmaceutical JSC
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email